Semax
ExperimentalNootropic / Research-onlyExperimental
Nootropic for cognitive research.
For research use only.
Key Facts
- CAS
- 80714-61-0
- Molecular Weight (MW)
- 813.92 g/mol
- Half-life
- ~20-30 minutes (nasal)
- Unit
- mcg
- Administration Route
- Intranasal or SubQ
- Frequency
- 1-3x daily
- Last updated
- 12/18/2025
- Targets
- BDNFEnkephalins
Overview
Nootropic for cognitive research.
Protocol
- Dosage Range
- 300-900 mcg
- Frequency
- 1-3x daily
- Cycle
- 4-6 weeks on, 2-4 off
- Administration Route
- Intranasal or SubQ
- Reconstitution Guide
- 3 mL BAC for 30 mg vial
Science
Mechanism of Action
BDNF upregulation, neuroplasticity.
Targets
BDNFEnkephalins
Studies
- — Journal/year not available
Benefits
Cognitive enhancementNeuroprotectionStress resilience
Potential Side Effects
- Nasal irritation
- Headache